AGL 40.39 Increased By ▲ 0.38 (0.95%)
AIRLINK 126.80 Decreased By ▼ -1.19 (-0.93%)
BOP 6.60 No Change ▼ 0.00 (0%)
CNERGY 4.51 Decreased By ▼ -0.09 (-1.96%)
DCL 8.52 Increased By ▲ 0.04 (0.47%)
DFML 41.75 Increased By ▲ 0.27 (0.65%)
DGKC 86.90 Increased By ▲ 0.32 (0.37%)
FCCL 32.30 Increased By ▲ 0.16 (0.5%)
FFBL 65.00 Decreased By ▼ -0.42 (-0.64%)
FFL 10.15 Decreased By ▼ -0.10 (-0.98%)
HUBC 109.58 Decreased By ▼ -0.91 (-0.82%)
HUMNL 14.60 Decreased By ▼ -0.15 (-1.02%)
KEL 5.12 Decreased By ▼ -0.01 (-0.19%)
KOSM 7.55 Increased By ▲ 0.43 (6.04%)
MLCF 41.30 Decreased By ▼ -0.35 (-0.84%)
NBP 59.53 Decreased By ▼ -0.56 (-0.93%)
OGDC 194.99 Increased By ▲ 0.30 (0.15%)
PAEL 28.27 Increased By ▲ 0.32 (1.14%)
PIBTL 7.77 Decreased By ▼ -0.23 (-2.88%)
PPL 152.49 Increased By ▲ 1.32 (0.87%)
PRL 26.65 Decreased By ▼ -0.23 (-0.86%)
PTC 16.10 Increased By ▲ 0.10 (0.63%)
SEARL 79.06 Increased By ▲ 0.86 (1.1%)
TELE 7.47 Increased By ▲ 0.08 (1.08%)
TOMCL 35.49 Decreased By ▼ -0.18 (-0.5%)
TPLP 8.30 Increased By ▲ 0.39 (4.93%)
TREET 16.05 Increased By ▲ 0.16 (1.01%)
TRG 53.00 Increased By ▲ 0.24 (0.45%)
UNITY 26.75 Increased By ▲ 0.20 (0.75%)
WTL 1.25 Decreased By ▼ -0.02 (-1.57%)
BR100 9,892 Decreased By -28 (-0.28%)
BR30 30,712 Decreased By -39.5 (-0.13%)
KSE100 93,234 Increased By 9.5 (0.01%)
KSE30 28,899 Increased By 13.7 (0.05%)

LONDON: British stocks rose on optimism over a Covid-19 vaccine on Monday, although gains in the FTSE index were curbed by a fall in shares of AstraZeneca after the drugmaker's candidate was less effective than others in trials.

The mid cap index added 0.4%, while the FTSE 100 fell 0.3%, with AstraZeneca marking its worst day in nearly six months with a 3.8% fall. AstraZeneca said the average efficacy of its vaccine, which is being developed with the University of Oxford, was at 70% in its late-stage trial.

Although the British drugmaker said its potential vaccine can be 90% effective, its average rate was lower than for Pfizer-BioNTech's and Moderna's, which showed efficacy rates of about 94% to 95%. In corporate news, Cineworld Group jumped nearly 20% after it secured waivers for its debt covenants until June 2022, along with $450 million in new loans.

"Even though the late stage trials were better than expected, AstraZeneca's shares didn't get a booster shot," Susannah Streeter, senior investment and markets analyst, Hargreaves Lansdown, said of the news.

"It has though added to the overall positivity washing around the financial markets about a faster end to the pandemic."

Comments

Comments are closed.